Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (91-100 of 304) with videos related to

Pageof 31
Sort By:
Arthritis Care & Research|October 6, 2011
Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effectsAndrew L Mammen, Katherine Pak, Emma K Williams, et al.
Human Gene Therapy|December 5, 2013
Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapyValerie Ferreira, Jaap Twisk, Karin Kwikkers, et al.
Journal of Clinical Medicine|October 16, 2024
Clinical Expression of Familial Hypercholesterolemia in Patients from France and French Canada Carrying Identical-by-Descent Pathogenic <i>LDLR</i> Gene Variants: A Proof-of-Concept StudyMiriam Larouche, Olivier Bluteau, Alain Carrié, et al.
The American Journal of Cardiology|June 29, 2002
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery diseaseJulie St-Pierre, Isabelle Lemieux, Marie-Claude Vohl, et al.
Lancet (London, England)|May 29, 2012
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trialEvan A Stein, Dan Gipe, Jean Bergeron, et al.
Atherosclerosis|May 19, 2005
Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemiaJean-Charles Hogue, Benoît Lamarche, Daniel Gaudet, et al.
Diabetes Care|October 16, 2007
Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in womenPatricia Blackburn, Isabelle Lemieux, Benoît Lamarche, et al.
Metabolism: Clinical and Experimental|July 8, 2011
Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in womenPatricia Blackburn, Isabelle Lemieux, Benoît Lamarche, et al.
Journal of Medical Economics|February 23, 2013
Medical resource use and costs associated with chylomicronemiaDaniel Gaudet, James Signorovitch, Elyse Swallow, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Prevalence of lifestyle risk factors in myotonic dystrophy type 1Cynthia Gagnon, Maud-Christine Chouinard, Luc Laberge, et al.
Pageof 31

Showing results (91-100 of 304) with videos related to

Sort By:
Pageof 31
Arthritis Care & Research|October 6, 2011
Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effectsAndrew L Mammen, Katherine Pak, Emma K Williams, et al.
Human Gene Therapy|December 5, 2013
Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapyValerie Ferreira, Jaap Twisk, Karin Kwikkers, et al.
Journal of Clinical Medicine|October 16, 2024
Clinical Expression of Familial Hypercholesterolemia in Patients from France and French Canada Carrying Identical-by-Descent Pathogenic <i>LDLR</i> Gene Variants: A Proof-of-Concept StudyMiriam Larouche, Olivier Bluteau, Alain Carrié, et al.
The American Journal of Cardiology|June 29, 2002
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery diseaseJulie St-Pierre, Isabelle Lemieux, Marie-Claude Vohl, et al.
Lancet (London, England)|May 29, 2012
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trialEvan A Stein, Dan Gipe, Jean Bergeron, et al.
Atherosclerosis|May 19, 2005
Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemiaJean-Charles Hogue, Benoît Lamarche, Daniel Gaudet, et al.
Diabetes Care|October 16, 2007
Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in womenPatricia Blackburn, Isabelle Lemieux, Benoît Lamarche, et al.
Metabolism: Clinical and Experimental|July 8, 2011
Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in womenPatricia Blackburn, Isabelle Lemieux, Benoît Lamarche, et al.
Journal of Medical Economics|February 23, 2013
Medical resource use and costs associated with chylomicronemiaDaniel Gaudet, James Signorovitch, Elyse Swallow, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Prevalence of lifestyle risk factors in myotonic dystrophy type 1Cynthia Gagnon, Maud-Christine Chouinard, Luc Laberge, et al.
Pageof 31